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httpA modiﬁed stapling technique for the repair of an
aneurysmal autogenous arteriovenous ﬁstula
Matteo Tozzi, MD,a,b Marco Franchin, MD,b,c Giuseppe Ietto, MD,b,c Gabriele Soldini, MD,b,c
Corrado Chiappa, MD,b,c Giulio Carcano, MD,b,c Patrizio Castelli, MD,a,b and
Gabriele Piffaretti, MD, PhD,a Varese, Italy
Objective: An alternative surgical technique for the repair an aneurysmatic arteriovenous ﬁstula (AVF) using a staple
remodeling operation has been developed and the results are reported.
Methods: All patients presenting with an aneurysmatic autogenous AVF of the upper extremities between January 2012
and December 2013 were included in the analysis. The AVF was approached laterally along the entire aneurysm and then
remodeled using a stapler on the lateral side of the vein wall. All stenotic segments were excised. Follow-up included a
clinical visit and echo color Doppler of the ﬁstula and was performed 7, 15, and 30 days after the intervention and every
6 months thereafter.
Results: We treated 14 patients (nine men [64.3%]) with a median age of 65 years (interquartile range [IQR], 62.5-
69 years). Elective interventions were performed in 12 patients (85.7%), and two underwent emergency treatment because
of postcannulation bleeding. Technical success was achieved in all cases. The mean duration of the intervention was
75 minutes (IQR, 61.15-83.45 minutes). No in-hospital deaths or major morbidities were observed. Median hospitali-
zation time was 24 hours (IQR, 25-38 hours). Postoperative puncture was performed after a median delay of 12.5 hours
(IQR, 12-17 hours). No patient was lost during the follow-up, which was a median of 16.5 months (IQR, 14-
23 months). Primary functional patency was 12 of 14 (85.7%). Pseudoaneurysm, bleeding, hematoma, or infection was
not observed.
Conclusions: In our experience, the stapling technique proved to be easy, fast, and safe. Early follow-up outcomes showed
excellent primary patency and conﬁrmed the effectiveness of the technique because local complications were never
observed. (J Vasc Surg 2014;60:1019-23.)Autogenous arteriovenous ﬁstula (AVF) is the ﬁrst-line
treatment for patients with end-stage renal disease who
require hemodialysis (HD), as recommended by the clinical
practice guidelines developed by the Society for Vascular
Surgery and by the European Vascular Access Society
(VAS).1,2 AVFs have higher patency and lower complication
rates compared with prosthetic grafts; unfortunately, they
are not free of risks, which include thrombosis and failure
to mature, bleeding, infection, pseudoaneurysm, seroma,
ischemia or steal syndrome, venous hypertension, and neu-
ropathy.3,4 Arteriovenous dilatation makes vascular puncture
easier during HD, but extraordinary enlargement might be
prone to rupture, with massive bleeding, skin atrophy, and
ulceration with the risk of infection and thrombosis that
might compromise HD.1,3 In these situations, surgery is
indicated.the Vascular Surgery,a Center for Research on Organ Transplanta-
n,b and General Surgery,c Department of Surgery and Morphological
iences, University of Insubria School of Medicine, Circolo University
eaching Hospital.
or conﬂict of interest: none.
rint requests: Gabriele Piffaretti, MD, PhD, Vascular Surgery, Depart-
ent of Surgery and Morphological Sciences, Circolo University Hospi-
l, University of Insubria School of Medicine, Via Guicciardini, 9, 21100
arese, Italy (e-mail: gabriele.piffaretti@uninsubria.it).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2014 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2014.04.012Although short-term results of endovascular stent
grafting have been reported to be satisfactory in recent re-
ports, surgery is a thorough solution that provides durable,
better results in most patients.5,6 Surgical treatment of an
aneurysmal autogenous AVF generally involves resection
and placement of an interposition graft or a bypass around
the lesion. These operations are straightforward and suc-
cessful but require prosthetic grafts in most cases.3,7 In
contrast, aneurysmoplasty preserves the autogenous AVF
and is effective. Recently, a stapling technique has been
described to have few complications and good long-term
results.8 We report the results of the repair of upper ex-
tremity aneurysmal autogenous AVFs using a modiﬁed
intervention with the stapling technique.
METHODS
All patients presenting with an aneurysmal autogenous
AVF of the upper extremities between January 2012 and
December 2013 were identiﬁed. Excluded from the ﬁnal
analysis were nonautogenous AVFs and deﬁnitive closure
of an aneurysmal AVF with (n ¼ 8 [30.7%]) and without
(n ¼ 4 [15.4%]) graft interposition. This is a single-
center experience with a retrospective analysis of prospec-
tively collected data. Every patient signed the informed
consent and the Institutional Review Board monitored
and approved this study.
Indications for intervention included thrombosis, difﬁ-
cult HD, skin erosion, steal syndrome, rupture or bleeding,
and a diameter >15 mm.9 All interventions were per-
formed by one senior vascular surgeon (M.T.). All patients1019
Fig. Intraoperative ﬁndings and technical aspects. Multiple aneurysms (*) and interposed stenoses (long arrows)
following the arterial inﬂow (I) are seen (A) externally and (B) internally after a lateral skin incision. C, Aneurysm
remodeling with the stapler. D, Note the intense circumferential intimal hyperplasia of the stenotic segment. E, End-to-
end anastomosis (dotted ring) is shown between the two edges of the excised aneurysmatic segment. F, The ﬁnal aspect of
the tubulization is shown, with the rectilinear staple line (short arrows) and the end-to-end anastomosis (dotted ring).
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1020 Tozzi et al October 2014were examined preoperatively with echo color Doppler to
assess the AVF ﬂow, to evaluate the characteristics of the
vein aneurysm, and to detect the stenotic segments among
multiple aneurysms. Computed tomography angiography
(CTA) of the chest and upper extremities was used selec-
tively when a central venous stenosis (eg, intrathoracic sub-
clavian or innominate veins) was suspected, in patients with
morbid obesity (body mass index >30 kg/m2), absent pe-
ripheral pulses, and history of thrombosis or phlebitis. Exclu-
sion criteria for the application of this technique were the
presence of a diffuse ﬁbrotic stenosis affecting the venous
outﬂow and an AVF ﬂow rate of <500 mL/min.1
Surgical technique. Interventions were performed in
an operating theater equipped with a mobile C-arm.
Each patient received short-term antibiotic prophylaxis
with vancomycin (1 gram) at the induction. Locoregional
plexus block or general anesthesia with orotracheal intu-
bation were left to the discretion of the anesthesiologist. A
skin incision was made laterally along the entire aneurysmal
AVF (Fig, A and B). The arterial inﬂow was clamped, and
the outﬂow was opened to decompress and collapse the
vein to obtain the most appropriate caliber to perform the
reconstruction with the stapler.
The AVF was remodelled using the Echelon Flex 45
Endopath (Ethicon, Somerville, NJ), an articulating linear sta-
pler with vascular cartridges, on the lateral side of the vein wall
to preserve the upper venous wall and facilitate an early punc-
ture. The stapler was positioned along the longitudinal axis of
the aneurysm to obtain a tubulization of the vessel that was as
straight as possible (Fig, C). The ﬁnal AVF diameter should
have been shaped to the nearest nonaneurysmal vein.
We resected the aneurysm ﬁrst, the stenotic segments
were identiﬁed and excised, and thereafter, an end-to-endanastomosis was performed between the two edges (Fig,
D-F) with 6-0 expanded polytetraﬂuoroethylene suture
(Gore-Tex; W. L. Gore and Associates, Flagstaff; Ariz).
The excision suture line was performed at the end of the
staple line. Final completion angiography was used selec-
tively to conﬁrm and treat central venous stenoses that
were detected preoperatively. The excised aneurysms
were sent for histologic evaluation.
Postoperative treatment and follow-up. Postopera-
tively, all patients started clopidogrel bisulfate (Plavix;
Sanoﬁ-Aventis SpA, Milan; Italy), 75 mg once daily, and
acetylsalicylic acid (Cardioaspirin; Bayer SpA, Milan, Italy),
100 mg once daily. Follow-up included a clinical visit and
an echo color Doppler examination at 7, 15, and 30 days
after the intervention and every 6 months thereafter.
Deﬁnition and data analysis. Deﬁnition and out-
comes criteria were deﬁned accordingly to the Committee
on Reporting Standards of the Society for Vascular Surgery
and the American Association for Vascular Surgery on AV
accesses.10 Clinical data were collected prospectively in a
dedicated Excel database (Microsoft Corp, Redmond,
Wash). Data are presented as median with the interquartile
range (IQR) for continuous variables and as number
(percentage) for categoric variables.
RESULTS
Final analysis included 14 patients, including nine men
(64.3%), with a median age of 65 years (IQR, 62.5-
69 years). The demographic data and the characteristics
of the aneurysms are presented in Table I. Elective inter-
ventions were performed in 12 patients (85.7%), and two
underwent emergency treatment because of postcannula-
tion bleeding. The mean time from AVF creation and
Table I. Clinical and anatomic risk factors of patients
with an aneurysmal arteriovenous ﬁstula (AVF)
Variablea Patients (N ¼ 14)
Demographic data
Age, years 64 6 14
Male sex 9 (64.3)
Time to treatment, months 28.6 6 13.4
Comorbidity
Hypertension 10 (71.4)
Hypercholesterolemia 7 (50.0)
Ischemic heart disease 6 (42.9)
Diabetes mellitus 3 (21.4)
Body mass index >30 kg/m2 2 (14.3)
COPD 2 (14.3)
Aneurysm characteristics
Aneurysms per AVF 3 (2-4)
Stenosis per AVF 2 (1-3)
Central venous stenosis 3 (21.4)
Nondominant arm 12 (85.7)
Symptomatic 9 (64.3)
Skin erosion 7 (77.8)
Difﬁcult HD 6 (66.7)
Pain 4 (44.4)
Bleeding 2 (22.2)
COPD, Chronic obstructive pulmonary disease; HD, hemodialysis.
aContinuous data are shown as the mean 6 standard deviation or the mean
(range) and categoric data as number (%).
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gional anesthesia was used in 10 patients (71.4%) and gen-
eral anesthesia in four (28.6%).
The AVF conﬁgurations were radial-cephalic in seven
(50%) and in the radial-antecubital forearm in seven
(50%). Technical success was achieved in all cases. No
intraoperative thrombosis was observed. The median dura-
tion of the intervention was 75 minutes (IQR, 61.15-
83.45 minutes). The median number of staple loads was
1 (IQR, 1-1.75). Packed red blood cells transfusion was
never needed. All patients had at least two aneurysms
excised, with a median of 2 aneurysms (IQR, 1-2) per
AVF, and all patients had at least one stenotic segment,
with a median of two (IQR, 1-3) stenotic lesions per
AVF. Preoperatively, a central venous stenosis involving
the axillary vein was detected in three patients (21.4%).
They were treated with transluminal angioplasty, with sup-
port by a 10 mm 10 cm Viabahn stent graft (W. L. Gore
& Associates) in two patients.
There were no in-hospital deaths, and no major local or
systemic complications were observed. Median hospitaliza-
tion time was 29.5 hours (IQR, 24.2-32.7 hours). At
discharge, patency of the AVF was 100%. Histologic eval-
uation revealed a true aneurysm in all cases, with a typical
presence of ﬁbrosis of the lamina media.
Early cannulation was successfully performed in all cases:
the median delay was 12.5 hours (IQR, 12-13.75 hours).
No patient was lost during the follow-up; median follow-
up was 16.5 months (IQR, 14-20.5 months). Primary func-
tional patency was maintained in all but two patients
(14.3%) in whom grade 3 AVF malfunction occurred.They were ultimately treated with the resection of the
AVF and the interposition of a 6-mm heparin-bonded Acu-
seal graft (W. L. Gore) between the radial artery and the
basilic vein (Table II).
No mechanical neuropathy was observed: one patient
(7.1%) presented with thenar eminence pain and pares-
thesia that resolved after 2 months of therapy with
75 mg pregabalin (Lyrica; Pﬁzer Ltd, Sandwich, United
Kingdom). No further complications, such as pseudoa-
neurysm, bleeding, hematoma, or infection, were observed.
DISCUSSION
Complications still afﬂict autogenous AVFs: in partic-
ular, a review by Huber et al4 reported that the incidence
of aneurysm formation in the upper extremity AVFs ranged
between 0% and 6%.4,10 When an aneurysm is extraordi-
narily enlarged or is steadily and rapidly growing, surgical
repair should be indicated.3,11 Ligation of the AVF with
interposition of a new autogenous or prosthetic graft has
been the preferred technique in most patients.7,11 More
recently, endovascular stent grafts have been used success-
fully, but mainly for focal lesions.5,6 Regardless of the type
of prosthetic grafts, they have been repeatedly shown to be
associated with lower patency rates and increased risk of
infection compared with autogenous AVFs: these are the
main reasons the merits of the preservation procedures
have been reconsidered.10-17 We agree with other authors
in favor of the fact that AVFs that have worked effectively
for many months or years should be preserved without the
introduction of prosthetic graft. The presence of an aneu-
rysm is simply a marker of an older graft that is less likely
to fail, having passed the selection process.18
Different techniques have been described to preserve
the function of an aneurysmal autogenous AVF. In their se-
ries, Woo et al13 and Bachleda et al16 resected the redun-
dant AVF and reshaped it over a rubber catheter or
Hegar dilatator, respectively, to optimize the caliber of
the access reconstruction. Lo et al12 proposed a technique
in which the “excess” wall is plicated by a running suture
along the entire length and back. These techniques were
effective, but we believe they are laborious and do not
eradicate the problem from the beginning: multiple stages
were required to repair multiple aneurysms just to maintain
another section of functional access for the HD.
We adopted a different technique of aneurysmoplasty
that was ﬁrst proposed by Pierce et al,8 who used a stapler
to repair the aneurysmal access. Their report included 12
patients, with no perioperative complications and only
two recurrent aneurysms at a mean follow-up of 29 months.
The technique is simple, takes a short time to be per-
formed, and is without early major complications; in addi-
tion, the AVF is repaired in place without needing a vein or
a prosthetic graft. Pasklinsky et al15 is also reported to have
opened to this technique because it would seem safe and
logical.
The technique also proved to be easy and safe in our
experience. Early primary patency was excellent, and no
major complications were observed. We used it also in a
Table II. Description of the case series
Pt
Age,
years
Anesthesia
(type)
AVF type
(conﬁguration)
AVF duration,
months
Aneurysm/
stenosis, No.
Aneurysm
Ø, mm
Central venous
stenosis
(adjunctive procedure) Complication
Follow-up,
months
1 74 LRPB RA 24 2/2 20 23
2 78 GA RA 48 3/2 25 Grade 3 malfunction 22
3 38 LRPB RC 15 1/1 28 Grade 3 malfunction 21
4 56 LRPB RA 36 2/1 40 20
5 58 LRPB RC 24 3/2 30 2 (TA þ stent) 20
6 71 LRPB RC 48 2/1 20 18
7 70 LRPB RA 13 4/3 15 15
8 74 GA RC 24 3/2 30 13
9 61 LRPB RA 36 2/1 26 Thenar pain 12
10 43 LRPB RC 12 3/1 30 1 (TA þ stent) 10
11 79 GA RC 12 4/2 22 8
12 76 LRPB RA 48 3/2 18 6
13 74 GA RA 24 2/2 23 1 (TA) 4
14 44 LRPB RC 36 3/3 20 1
Ø, Diameter; AVF, arteriovenous ﬁstula; GA, general anesthesia; LRPB, locoregional plexus block; RA, radial-antecubital; RC, radial-cephalic; TA, trans-
luminal angioplasty.
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treatment to obtain a rapid and effective control of a
bleeding access. Another advantage is that conventional
surgery is not precluded later.
Our results are similar to those reported by Pierce
et al,8 although we introduced some modiﬁcations that
deserve a few comments. First, we excised all of the stenotic
segments interposed between the aneurysms. Extreme,
diffuse enlargement of the AVF has been associated with
the presence of proximal venous stenosis, which might
explain the lower number of recurrent aneurysm complica-
tions in our series.3,8,11,15
Second, we vented the aneurysm to obtain a more pre-
cise control of the stapler and to optimize the aneurysmo-
plasty. This maneuver leaves intact the upper side of the
access for an early puncture while avoiding the risk of dis-
rupting the staple line.12,14,16 This is very advantageous
because we did not need a central venous catheter to
temporarily perform the HD.
Third, we used a linear stapler with dedicated vascular
sutures that did not require additional stitches to reinforce
the staple line, as occurred in other reports. We believe this
occurrence distorts the spirit in which it was decided to use
a stapler.8 Admittedly, this technique has one relevant
drawback: all of these positive aspects are counterbalanced
by the disadvantage of increased expenses due to the stapler
cost.
One of the concerns that could be debated in our tech-
nique is the maintenance of the anterior aspect of the
vascular access wall.10,12 Studies have shown that the devel-
opment of an AVF aneurysm is determined by multiple
punctures and hemodynamic stresses on a weakened AVF
wall.10,11
Surprisingly, we did not have recurrence of aneurysms,
as Pierce et al8 reported in their experience. Yet, as we have
said, one of the most important differences compared with
their experience is that we excised all of the stenoticsegments interposed between the aneurysms. We do not
have histologic evidence of this fact, but we believe that
the most important factor for the development of the
AVF aneurysm is the presence of these stenoses.10,11 This
may ﬁnd support in the fact that two failures occurred for
a selection error of the patients during our learning phase:
in fact, these two cases occurred in the ﬁrst four we per-
formed. In particular, malfunction of the AVF was deter-
mined by the inadequate evaluation of the venous
outﬂow, characterized by a ﬁbrotic aspect that was under-
estimated although already present before the intervention.
We did not identify a severe stenosis intraoperatively or
during the follow-up; rather, we observed a framework of
widespread degeneration borne of the cephalic vein wall.
One of the most important aspects in vascular surgery
is the quality control of the grafts, whether native or pros-
thetic, and AVFs are not exempt. We never used periproce-
dural ﬁstulography; rather, we opted for a selective
intraoperative use. We believe preoperative CTA was very
helpful. We optimized the operative strategy by identifying
those patients who required subsequent intraoperative
correction of central venous stenoses that could have
threatened the function of the stapled graft. Also, the
two failures should have been ascribed to a misinterpreta-
tion of the venous outﬂow stenosis: this may have been
an error during our learning phase, but identifying it by
preoperative CTA would have been possible.
The last aspect that could create a debate about our se-
ries is the postoperative therapy regimen based on clopi-
dogrel and aspirin. Brieﬂy, a previous randomized
controlled trial did not show the superiority of single vs
dual antiplatelet therapy in the HD population.19 Howev-
er, we should consider that the study concluded prema-
turely with one certainty and one speculation: the
certainty was due to the high number of bleeding compli-
cations, but with a speculation only about the relevance of
dual antiplatelet therapy because it was only hypothesized
JOURNAL OF VASCULAR SURGERY
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conducted on prosthetic AVFs; in our experience of autog-
enous AVFs, major bleeding complications were never
observed, which is another merit of this technique. These
data ﬁnd support in the results of another randomized trial.
Dember et al20 demonstrated that clopidogrel reduces the
incidence of early thrombosis of new autogenous access.
The study has several limitations: the cohort was small
and the study was retrospective in nature and lacked com-
parison with another technique. Despite these limitations,
our patient cohort is currently the largest available on
aneurysmoplasty performed with a modiﬁed stapling tech-
nique performed by a single senior surgeon, which means
homogeneity of the procedural data.
CONCLUSIONS
In our experience, the stapling technique to repair
aneurysmal AVFs was easy, fast, and safe, and also effective
for emergency treatment. This technique preserved the
function of the autogenous AVF and permitted early HD
cannulation. Early follow-up outcomes showed excellent
primary patency and conﬁrmed the effectiveness of the
technique because local complications were never
observed.
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